Warp Drive Bio deploys a proprietary "genomic search engine" and complementary technologies to reveal natural products encoded in microbial genomes and convert those genomes into drug candidates. The company is developing methods to induce production of novel natural products and to determine their modes of action, targeting biological pathways that are often considered "undruggable." Warp Drive Bio was founded by Third Rock Ventures and Dr. Gregory Verdine, with co-founders Dr. George Church and Dr. James Wells, and was incubated at Third Rock Ventures for two years. The company launched in 2011 through a strategic partnership with Sanofi and financing from Third Rock Ventures and Greylock Partners. Warp Drive Bio was created as a fully independent company that retains strategic direction, operational management and full rights to select assets while pursuing collaborative programs. The launch and partnership provide full funding to aggressively advance its core research and development strategy over at least the next five years.

Total raised

$75M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2012